Emanuela Guttoriello Pharmd, Mba Email & Phone Number

Milan, It

Milano

Responsible for reinforcing Accord awareness in Specialty Brand portfolio by enhancing products benefits in autoimmune and oncology therapeutic areas; for preparing launch of first Accord's originator; for helping retail business start-up by developing original and digital projects in cooperation with Accord Corporate team.

Milano

Responsible for driving Accord Italy's transformation towards a company leader in specialty and oncology fields. Therapeutic areas managed: autoimmune, osteoporosis, onco-haematology, transplant, breast oncology.

Milano, Italia

Management of Multiple Sclerosis, Migraine and CNS portfolio; responsible for marketing activities for international cluster including Italy, Greece, Croatia, Slovenia, Serbia, Bulgaria.

Milano, Italia

Development of patient identification and conversion tactics, patients' journey and diagnostic implementation in top accounts, leverage of National Patients Fund options for enhance access, management of regional market access strategies, improvement of disease awareness through national and local opinion leader management, champions’ development in main accounts, congresses and CME event. Alignment with Global/EMEA strategy, costs control, segmentation & targeting, sales force effectiveness.

Management of antidepressant portfolio by enhancing Ciplalex®/Entact® lost of patent and new antidepressive Brintellix® launch preparation by applying an integrated and synergistic strategic approach

Milano, Italia

Launch of Abilify Maintena® in co-promotion with Otsuka in schizophrenia

Utrecht, Paesi Bassi

Management of rare diseases portfolio including Oncaspar (treatment of acute lymphoblastic leukemia), Carnitine supplementation (Carnitine deficiency syndrome), Cystaran (treatment of corneal cystine crystal accumulation in patients with cystinosis). Responsible for both marketing & sales headcounts on the field.

Utrecht, Paesi Bassi

Business development of Nutraceutical Portfolio: high quality supplements with indications in men fertility, erectile dysfunction, urology, immunity and energy boost, in the main European countries (France, UK, Spain, Germany, Netherlands, Russia)Management of sales forces all around Europe.

Monza E Brianza, Italia

Product Manager Nephrology therapeutic area - management of Mircera (erythropoietin used to treat anemia in people with chronic kidney disease) by assuring listing in the Regional/Hospital formulary in cooperation with Market Access structure; OLs management, congresses, events, promotional tools, strategic marketing plan definition & implementation, long term strategic and financial plans and forecast.

Launch of Pradaxa (dabigatran) in the orthopedic indication

Milano, Italia

Launch of Xeritsar (duloxetine) in co-marketing with Cymbalta (Eli-Lilly), an antidepressant drug with new mechanism of action. Main area of focus: key player segmentation and HCPs targeting, patients flow assessment, competitive market definition, localization of global strategy, promotional tool kit implementation, key opinion leaders management, congresses and event organization, forecast and budget control.

Roma, Italia

Management of Diabetes portfolio: Diamicron lost of patent transition and new Diamicron30 launch preparation; brand awareness and equity assessment; minimization of generic erosion and brand cannibalization; definition of extension line brand positioning in order to maximize the portfolio

Roma, Italia

Medical Representative - Rome area

Pnl Practitioner, Comunicazione Efficace E Tecniche Di Pnl

Market Access & Affari Istituzionali, Market Access

Mba, Master Business Administration

Laurea In Chimica E Tecnologia Farmaceutiche, 110/110

Erasmus Exchange Program, Montpellier - France

Pharmacist Vacancy Student, London - Uk